Tech Company Financing Transactions
Heartflow Funding Round
Baillie Gifford, private investors and Wellington Management Company participated in a $240 million Series E funding round for Heartflow. The financing round closed on 2/15/2018.
Transaction Overview
Company Name
Announced On
2/15/2018
Transaction Type
Venture Equity
Amount
$240,000,000
Round
Series E
Investors
Baillie Gifford (Peter Singlehurst)
Proceeds Purpose
The company will use the proceeds from this financing to ramp up commercial expansion of the HeartFlow FFRct Analysis, continued technology innovation and additional clinical studies.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1400 Seaport Blvd. Bldg B
Redwood City, CA 94063
USA
Redwood City, CA 94063
USA
Phone
Website
Email Address
Overview
Non-invasive coronary artery disease detection.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dana Mead
Chief Medical Officer
Campbell Rogers
Chief Technical Officer
Charles Taylor
VP - Bus. Development
Lance Scott
VP - General Counsel
Noemi Espinosa
VP - Human Resources
Renata Naoumov
Browse more venture capital transactions:
Prev: 2/15/2018: InXpo venture capital transaction
Next: 2/15/2018: SEEVA venture capital transaction
Share this article
Where The Data Comes From
We record every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs